Klaus Breuel

Title: Klaus Breuel: Innovator in Ergoline Derivatives

Introduction

Klaus Breuel is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the production of ergoline derivatives. His innovative work has led to the development of a patented process that enhances the production of valuable alkaloids.

Latest Patents

Klaus Breuel holds a patent for a process for the fermentation production of ergoline derivatives. This patent involves creating a submerged culture under aerobic conditions using spores from a strain of Claviceps purpurea. The process includes the extraction of formed alkaloids and their conversion into pharmaceutically acceptable acid addition salts. This innovation is crucial for the pharmaceutical industry, as it provides a method for producing important compounds like ergometrine.

Career Highlights

Klaus Breuel has worked at Veb Arzneimittelwerk Dresden, where he has been instrumental in advancing research and development in the field of pharmaceuticals. His expertise in fermentation processes has positioned him as a key figure in the production of ergoline derivatives.

Collaborations

Throughout his career, Klaus Breuel has collaborated with several professionals, including Eva Borowski and Klaus Braun. These collaborations have contributed to the successful development of his patented processes and have fostered innovation within the company.

Conclusion

Klaus Breuel's contributions to the field of pharmaceuticals through his patented processes for ergoline derivatives highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future advancements in pharmaceutical production.